决定异体 CAR T 细胞排斥与扩增的细胞和分子机制
Cellular and molecular mechanisms determining allogeneic CAR T cell rejection and expansion.
我们评估了11例接受单一批次cemacabtagene ansegedleucel(cema-cel)治疗的大B细胞淋巴瘤患者,cemacabtagene ansegedleucel是一种异体抗CD19 CAR T产品。
英文原题:PDZ domains of PATJ facilitate immunological synapse formation to promote T cell activation.
我们的研究揭示了 PATJ 在免疫突触形成中的重要作用,并提供了一种提高 CAR-T 疗法疗效的方法。
高度有序的免疫突触(IS)结构对T细胞活化至关重要。PDZ结构域可能作为蛋白相互作用的停靠位点,参与IS形成。本研究探讨含10个PDZ结构域的PALS1相关紧密连接蛋白(PATJ)在IS形成中的作用及其对T细胞活化的影响。方法:为阐明PATJ的功能,我们构建了T细胞特异性条件性敲除Patj的小鼠模型,并在感染和癌症背景下评估体内外T细胞活化。采用共聚焦显微镜观察缺失Patj时T细胞与抗原呈递细胞之间IS的形成。我们使用包含不同PDZ结构域组合的一系列PATJ截短体,确定有效T细胞受体信号传导所需的最小结构域。随后将已鉴定的活性PDZ结构域整合至间皮素(MSLN)特异性嵌合抗原受体(CAR),评估其对CAR-T细胞抗实体瘤细胞毒性的影响。结果:T细胞活化期间PATJ表达迅速升高。在小鼠模型中,T细胞条件性敲除Patj会损害抗感染和抗肿瘤免疫。机制上,敲除Patj会阻碍IS形成,进而降低T细胞活化。我们进一步发现,将PATJ的活性PDZ结构域工程化整合到CAR结构中,可显著增强CAR-T细胞效应功能。结论:本研究揭示PATJ在IS形成中的重要作用,并为提高CAR-T疗效提供了一种方法。
BACKGROUND: The highly organized structures of the immunological synapse (IS) are crucial for T cell activation. PDZ domains might be involved in the formation of the IS by serving as docking sites for protein interactions. In this study, we investigate the role of the PALS1-associated tight junction protein (PATJ), which contains 10 PDZ domains, in the formation of IS and its subsequent impact on T cell activation. METHODS: To elucidate the function of PATJ, we generated murine models with conditional T cell-specific knockout of Patj and assessed T cell activation both in vitro and in vivo within the context of infection and cancer. We employed confocal microscopy to visualize the formation of IS between T cells and antigen-presenting cells in the absence of Patj . A series of PATJ truncations containing different combinations of PDZ domains was used to identify the minimal domain required for effective T cell receptor signaling. The identified active PDZ domain was then incorporated into mesothelin (MSLN)-specific chimeric antigen receptor (CAR) to evaluate its impact on CAR-T cell cytotoxicity against solid tumors. RESULTS: We observed a rapid increase in PATJ expression during T cell activation. Conditional knockout of Patj in T cells showed impaired immunity against infection and cancer in murine models. Mechanistically, ablation of Patj impedes IS formation, and thus reduces T cell activation. We further showed that engineering the active PDZ domain of PATJ into CAR structure significantly promoted the effector function of CAR-T cells. CONCLUSIONS: Our study reveals an important role of PATJ in the formation of IS and provides an approach to improve the efficacy of CAR-T therapy.
MEMBER ACCOUNT
登录成功会直接打开下一页。